136 related articles for article (PubMed ID: 15922475)
21. Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice.
Tian X; Li J; Zamek-Gliszczynski MJ; Bridges AS; Zhang P; Patel NJ; Raub TJ; Pollack GM; Brouwer KL
Antimicrob Agents Chemother; 2007 Sep; 51(9):3230-4. PubMed ID: 17576841
[TBL] [Abstract][Full Text] [Related]
22. High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease.
Ros JE; Libbrecht L; Geuken M; Jansen PL; Roskams TA
J Pathol; 2003 Aug; 200(5):553-60. PubMed ID: 12898590
[TBL] [Abstract][Full Text] [Related]
23. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Morgan RE; van Staden CJ; Chen Y; Kalyanaraman N; Kalanzi J; Dunn RT; Afshari CA; Hamadeh HK
Toxicol Sci; 2013 Nov; 136(1):216-41. PubMed ID: 23956101
[TBL] [Abstract][Full Text] [Related]
24. Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injury.
Zollner G; Thueringer A; Lackner C; Fickert P; Trauner M
Digestion; 2014; 90(2):81-8. PubMed ID: 25196354
[TBL] [Abstract][Full Text] [Related]
25. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.
Vanwijngaerden YM; Wauters J; Langouche L; Vander Perre S; Liddle C; Coulter S; Vanderborght S; Roskams T; Wilmer A; Van den Berghe G; Mesotten D
Hepatology; 2011 Nov; 54(5):1741-52. PubMed ID: 21800341
[TBL] [Abstract][Full Text] [Related]
26. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human liver drug transporters.
Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD
Drug Metab Dispos; 2010 Jul; 38(7):1072-82. PubMed ID: 20360302
[TBL] [Abstract][Full Text] [Related]
27. The mechanism of increased biliary lipid secretion in mice with genetic inactivation of bile salt export pump.
Gooijert KE; Havinga R; Wolters H; Wang R; Ling V; Tazuma S; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(5):G450-7. PubMed ID: 25552583
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes.
Jigorel E; Le Vee M; Boursier-Neyret C; Parmentier Y; Fardel O
Drug Metab Dispos; 2006 Oct; 34(10):1756-63. PubMed ID: 16837569
[TBL] [Abstract][Full Text] [Related]
29. Expression of hepatocyte transporters and nuclear receptors in children with early and late-stage biliary atresia.
Chen HL; Liu YJ; Chen HL; Wu SH; Ni YH; Ho MC; Lai HS; Hsu WM; Hsu HY; Tseng HC; Jeng YM; Chang MH
Pediatr Res; 2008 Jun; 63(6):667-73. PubMed ID: 18327154
[TBL] [Abstract][Full Text] [Related]
30. The role of lithocholic acid in the regulation of bile acid detoxication, synthesis, and transport proteins in rat and human intestine and liver slices.
Khan AA; Chow EC; Porte RJ; Pang KS; Groothuis GM
Toxicol In Vitro; 2011 Feb; 25(1):80-90. PubMed ID: 20888898
[TBL] [Abstract][Full Text] [Related]
31. Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients.
Geuken E; Visser DS; Leuvenink HG; de Jong KP; Peeters PM; Slooff MJ; Kuipers F; Porte RJ
Hepatology; 2005 Nov; 42(5):1166-74. PubMed ID: 16250035
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
[TBL] [Abstract][Full Text] [Related]
33. [Liver disease associated with hereditary defects of hepatobiliary transporters].
Wendum D
Ann Pathol; 2010 Dec; 30(6):426-31. PubMed ID: 21167428
[TBL] [Abstract][Full Text] [Related]
34. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
Stieger B
Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
[TBL] [Abstract][Full Text] [Related]
35. Bile salt excretory pump: biology and pathobiology.
Suchy FJ; Ananthanarayanan M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
[TBL] [Abstract][Full Text] [Related]
36. Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver.
Meier Y; Pauli-Magnus C; Zanger UM; Klein K; Schaeffeler E; Nussler AK; Nussler N; Eichelbaum M; Meier PJ; Stieger B
Hepatology; 2006 Jul; 44(1):62-74. PubMed ID: 16799996
[TBL] [Abstract][Full Text] [Related]
37. Glutamine attenuates obstructive cholestasis in rats via farnesoid X receptor-mediated regulation of Bsep and Mrp2.
Liu B; Li Y; Ji H; Lu H; Li H; Shi Y
Can J Physiol Pharmacol; 2017 Feb; 95(2):215-223. PubMed ID: 28051334
[TBL] [Abstract][Full Text] [Related]
38. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells.
Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB
Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292
[TBL] [Abstract][Full Text] [Related]
39. BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas.
Fujikura K; Yamasaki T; Otani K; Kanzawa M; Fukumoto T; Ku Y; Hirose T; Itoh T; Zen Y
Am J Surg Pathol; 2016 May; 40(5):689-96. PubMed ID: 26735860
[TBL] [Abstract][Full Text] [Related]
40. Multihormonal regulation of hepatic sinusoidal Ntcp gene expression.
Simon FR; Fortune J; Iwahashi M; Qadri I; Sutherland E
Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G782-94. PubMed ID: 15361361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
